BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Biotech Bay

  Novartis AG Has A History Of Charging High Prices For Drugs In Colombia

  November 2, 2016

   · 

  1 min read
• Drug Development

  Momenta And Mylan Initiate Phase 1 Clinical Trial For M834, A Proposed Biosimilar Of ORENCIA (Abatacept)

  November 2, 2016

   · 

  6 min read
• Drug Development

  DNAtrix, Inc. Announces First Patients Treated In Phase 2 Trial With DNX-2401 And KEYTRUDA

  November 2, 2016

   · 

  3 min read
• Drug Development

  Neurim Pharmaceuticals Announces Positive Top-Line Results From Pivotal Phase III Trial Of Paediatric Prolonged-Release Melatonin (“Pedprm”) For Sleep Disturbances In Children With Autism Spectrum Disorders (ASD)

  November 2, 2016

   · 

  2 min read
• Biotech Bay

  Kaiser Permanente Release: Infections During Infancy, Not Antibiotic Use, Are More Closely Associated With Childhood Obesity Risk

  November 2, 2016

   · 

  4 min read
• Drug Development

  Zynerba Announces Initiation Of STAR 2 Open-Label Extension Clinical Trial For ZYN002 CBD Gel In Adult Refractory Epilepsy Patients

  November 2, 2016

   · 

  5 min read
• Business

  CASMED To Report Third-Quarter 2016 Financial Results And Hold Conference Call On November 8

  November 2, 2016

   · 

  1 min read
• Business

  Concordia Announces New Leadership Appointments

  November 2, 2016

   · 

  7 min read
• Concordia Announces Second Cross Currency Swap Agreement

  November 2, 2016

   · 

  5 min read
• Business

  Verastem Licenses Duvelisib From Infinity Pharma

  November 2, 2016

   · 

  14 min read